| Mrs Sabrina Starr Shebes, AGNP, CCRN | |
|
994 W Jericho Tpke Ste 104, Smithtown, NY 11787-3211 | |
| (631) 543-1440 | |
| Not Available |
| Full Name | Mrs Sabrina Starr Shebes |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 994 W Jericho Tpke Ste 104, Smithtown, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629693536 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Timothy D. Groth Md Pc | 8921002320 | 25 |
News Archive
In the largest clinical trial to date to examine the efficacy of PARP inhibitor therapy in BRCA 1/2 carriers with diseases other than breast and ovarian cancer, the oral drug olaparib was found to be effective against advanced pancreatic and prostate cancers.
BioClinica, Inc., a global provider of clinical trial management services, will exhibit at the 46th Drug Information Association Annual Meeting from June 13-17, 2010 in Washington, D.C., where it will showcase the BioClinica eClinical Technology Suite as well as introduce the BioClinica Integrated Operations Platform.
A new discovery has shown why some people cannot give up tobacco and may lead to new anti-smoking treatments. The researchers have found a brain pathway which when defective leads to an uncontrollable desire to smoke. This is a "sub-unit" of a receptor protein sensitive to nicotine.
Metastatic melanoma has a poor prognosis, but treatment with high-dose interleukin-2 (IL2) can extend survival. Now, a combination of IL2 therapy and activation of patients' immune systems using personalized vaccines made from their own tumor cells has been shown to improve survival rates even more than IL2 alone, according to a new article in Cancer Biotherapy and Radiopharmaceuticals, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
According to a report published today in the Morbidity and Mortality Weekly Report of Centers for Disease Control and Prevention (CDC), 5% of women in the U.S. and its territories who had confirmed Zika virus infection during pregnancy had a baby or fetus with Zika virus-associated birth defects.
› Verified 1 days ago
| Entity Name | Timothy D. Groth Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720022015 PECOS PAC ID: 8921002320 Enrollment ID: O20060825000424 |
News Archive
In the largest clinical trial to date to examine the efficacy of PARP inhibitor therapy in BRCA 1/2 carriers with diseases other than breast and ovarian cancer, the oral drug olaparib was found to be effective against advanced pancreatic and prostate cancers.
BioClinica, Inc., a global provider of clinical trial management services, will exhibit at the 46th Drug Information Association Annual Meeting from June 13-17, 2010 in Washington, D.C., where it will showcase the BioClinica eClinical Technology Suite as well as introduce the BioClinica Integrated Operations Platform.
A new discovery has shown why some people cannot give up tobacco and may lead to new anti-smoking treatments. The researchers have found a brain pathway which when defective leads to an uncontrollable desire to smoke. This is a "sub-unit" of a receptor protein sensitive to nicotine.
Metastatic melanoma has a poor prognosis, but treatment with high-dose interleukin-2 (IL2) can extend survival. Now, a combination of IL2 therapy and activation of patients' immune systems using personalized vaccines made from their own tumor cells has been shown to improve survival rates even more than IL2 alone, according to a new article in Cancer Biotherapy and Radiopharmaceuticals, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
According to a report published today in the Morbidity and Mortality Weekly Report of Centers for Disease Control and Prevention (CDC), 5% of women in the U.S. and its territories who had confirmed Zika virus infection during pregnancy had a baby or fetus with Zika virus-associated birth defects.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Sabrina Starr Shebes, AGNP, CCRN 994 W Jericho Tpke Ste 104, Smithtown, NY 11787-3211 Ph: (631) 543-1440 | Mrs Sabrina Starr Shebes, AGNP, CCRN 994 W Jericho Tpke Ste 104, Smithtown, NY 11787-3211 Ph: (631) 543-1440 |
News Archive
In the largest clinical trial to date to examine the efficacy of PARP inhibitor therapy in BRCA 1/2 carriers with diseases other than breast and ovarian cancer, the oral drug olaparib was found to be effective against advanced pancreatic and prostate cancers.
BioClinica, Inc., a global provider of clinical trial management services, will exhibit at the 46th Drug Information Association Annual Meeting from June 13-17, 2010 in Washington, D.C., where it will showcase the BioClinica eClinical Technology Suite as well as introduce the BioClinica Integrated Operations Platform.
A new discovery has shown why some people cannot give up tobacco and may lead to new anti-smoking treatments. The researchers have found a brain pathway which when defective leads to an uncontrollable desire to smoke. This is a "sub-unit" of a receptor protein sensitive to nicotine.
Metastatic melanoma has a poor prognosis, but treatment with high-dose interleukin-2 (IL2) can extend survival. Now, a combination of IL2 therapy and activation of patients' immune systems using personalized vaccines made from their own tumor cells has been shown to improve survival rates even more than IL2 alone, according to a new article in Cancer Biotherapy and Radiopharmaceuticals, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
According to a report published today in the Morbidity and Mortality Weekly Report of Centers for Disease Control and Prevention (CDC), 5% of women in the U.S. and its territories who had confirmed Zika virus infection during pregnancy had a baby or fetus with Zika virus-associated birth defects.
› Verified 1 days ago